首页 > 最新文献

Hpb最新文献

英文 中文
Replacement of the main bile duct by bioprosthesis in an experimental porcine model (24-month results). 在实验猪模型中用生物假体置换主胆管(24 个月的结果)。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-30 DOI: 10.1016/j.hpb.2024.10.009
Eduardo E Montalvo-Javé, Benjamín León-Mancilla, Mariana Espejel-Deloiza, Jonathan Chernizky, Alan Valderrama-Treviño, María C Piña-Barba, César Montalvo-Arenas, Carlos Gutiérrez-Banda, Rita Dorantes-Heredia, Natalia Nuño-Lámbarri

Background: Cholecystectomy for conditions like iatrogenic injury during cholecystectomy can lead to complications such as bile duct injuries, necessitating alternative options like bioprosthesis.

Methods: This study evaluated a bioprosthesis's efficacy in maintaining bile duct continuity over 24 months in 16 male pigs.

Results: The bioprosthesis was implanted in the common bile duct of three-month-old animals, with follow-ups at 1, 6, 12, 18, and 24 months. Liver function remained stable, and biliary permeability was assessed through various imaging techniques. Despite mild stenosis, biliary flow was unimpeded. Histological analysis confirmed biliary epithelium presence in the regenerated area.

Conclusion: The bioprosthesis acted as a scaffold for tissue regeneration without compromising biliary function. Remnants of the bioprosthesis were observed but did not affect biliary excretion in the 24-month porcine model. This study highlights the bioprosthesis's potential in bile duct reconstruction, offering a safe and effective option for maintaining biliary continuity.

背景:胆囊切除术中的先天性损伤等情况会导致胆管损伤等并发症,因此需要生物假体等替代方案:本研究评估了生物假体在16头雄性猪体内维持胆管连续性24个月的效果:结果:将生物假体植入三个月大的动物的胆总管,并在 1、6、12、18 和 24 个月时进行随访。肝功能保持稳定,胆道通透性通过各种成像技术进行了评估。尽管胆管轻度狭窄,但胆汁流动畅通无阻。组织学分析证实,再生区域存在胆道上皮:结论:生物假体是组织再生的支架,不会影响胆道功能。在为期 24 个月的猪模型中,观察到了生物假体的残留物,但不会影响胆汁排泄。这项研究强调了生物假体在胆管重建中的潜力,为保持胆道连续性提供了一种安全有效的选择。
{"title":"Replacement of the main bile duct by bioprosthesis in an experimental porcine model (24-month results).","authors":"Eduardo E Montalvo-Javé, Benjamín León-Mancilla, Mariana Espejel-Deloiza, Jonathan Chernizky, Alan Valderrama-Treviño, María C Piña-Barba, César Montalvo-Arenas, Carlos Gutiérrez-Banda, Rita Dorantes-Heredia, Natalia Nuño-Lámbarri","doi":"10.1016/j.hpb.2024.10.009","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.009","url":null,"abstract":"<p><strong>Background: </strong>Cholecystectomy for conditions like iatrogenic injury during cholecystectomy can lead to complications such as bile duct injuries, necessitating alternative options like bioprosthesis.</p><p><strong>Methods: </strong>This study evaluated a bioprosthesis's efficacy in maintaining bile duct continuity over 24 months in 16 male pigs.</p><p><strong>Results: </strong>The bioprosthesis was implanted in the common bile duct of three-month-old animals, with follow-ups at 1, 6, 12, 18, and 24 months. Liver function remained stable, and biliary permeability was assessed through various imaging techniques. Despite mild stenosis, biliary flow was unimpeded. Histological analysis confirmed biliary epithelium presence in the regenerated area.</p><p><strong>Conclusion: </strong>The bioprosthesis acted as a scaffold for tissue regeneration without compromising biliary function. Remnants of the bioprosthesis were observed but did not affect biliary excretion in the 24-month porcine model. This study highlights the bioprosthesis's potential in bile duct reconstruction, offering a safe and effective option for maintaining biliary continuity.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning curve in robotic liver surgery: easily achievable, evolving from laparoscopic background and team-based. 机器人肝脏手术的学习曲线:容易实现,从腹腔镜背景发展而来,以团队为基础。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-20 DOI: 10.1016/j.hpb.2024.10.007
Francesca Ratti, Sara Ingallinella, Marco Catena, Diletta Corallino, Rebecca Marino, Luca Aldrighetti

Background: Limited and heterogeneous literature data necessitate a focused examination of the learning curve in robotic liver resections. This study aims to assess the learning curve of two surgeons from the same team with differing laparoscopic backgrounds.

Methods: Since February 2021, San Raffaele Hospital in Milan has implemented a robotic liver surgery program, performing 250 resections by three trained console surgeons. Using cumulative sum (CUSUM) analysis, the learning curve was evaluated for a Pioneer Surgeon (PS) with around 1200 laparoscopic cases and a New Generation Surgeon (NGS) with approximately 100 laparoscopic cases. Cases were stratified by complexity (38 low, 74 intermediate, 85 high).

Results: Both PS and NGS demonstrated a learning curve for operative time after 15 low-complexity and 10 intermediate-complexity cases, with high-complexity learning curves apparent after 10 cases for PS and 18 cases for NGS. Conversion rates remained unaffected, and neither surgeon experienced increased blood loss or postoperative complications. A "team learning curve" effect in terms of operative time emerged after 12 cases, suggesting the importance of a cohesive surgical team.

Conclusion: The robotic platform facilitated a relatively brief learning curve for low and intermediate complexity cases, irrespective of laparoscopic background, underscoring the benefits of team collaboration.

背景:由于文献资料有限且不尽相同,有必要对机器人肝脏切除术的学习曲线进行重点研究。本研究旨在评估来自同一团队、具有不同腹腔镜背景的两名外科医生的学习曲线:自 2021 年 2 月起,米兰圣拉斐尔医院开始实施机器人肝脏手术项目,由三名训练有素的控制台外科医生实施了 250 例切除手术。通过累积总和(CUSUM)分析法,对拥有约1200例腹腔镜手术的先锋外科医生(PS)和拥有约100例腹腔镜手术的新一代外科医生(NGS)的学习曲线进行了评估。病例按复杂程度分层(38 个低复杂病例、74 个中等复杂病例、85 个高复杂病例):结果:PS 和 NGS 在 15 例低度复杂病例和 10 例中度复杂病例后都显示出手术时间学习曲线,PS 在 10 例病例后和 NGS 在 18 例病例后显示出高度复杂病例学习曲线。转换率未受影响,两位外科医生的失血量和术后并发症均未增加。12 个病例后,在手术时间方面出现了 "团队学习曲线 "效应,这表明一个团结的手术团队非常重要:机器人平台为中低复杂度病例提供了相对较短的学习曲线,无论其腹腔镜背景如何,这凸显了团队合作的益处。
{"title":"Learning curve in robotic liver surgery: easily achievable, evolving from laparoscopic background and team-based.","authors":"Francesca Ratti, Sara Ingallinella, Marco Catena, Diletta Corallino, Rebecca Marino, Luca Aldrighetti","doi":"10.1016/j.hpb.2024.10.007","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.007","url":null,"abstract":"<p><strong>Background: </strong>Limited and heterogeneous literature data necessitate a focused examination of the learning curve in robotic liver resections. This study aims to assess the learning curve of two surgeons from the same team with differing laparoscopic backgrounds.</p><p><strong>Methods: </strong>Since February 2021, San Raffaele Hospital in Milan has implemented a robotic liver surgery program, performing 250 resections by three trained console surgeons. Using cumulative sum (CUSUM) analysis, the learning curve was evaluated for a Pioneer Surgeon (PS) with around 1200 laparoscopic cases and a New Generation Surgeon (NGS) with approximately 100 laparoscopic cases. Cases were stratified by complexity (38 low, 74 intermediate, 85 high).</p><p><strong>Results: </strong>Both PS and NGS demonstrated a learning curve for operative time after 15 low-complexity and 10 intermediate-complexity cases, with high-complexity learning curves apparent after 10 cases for PS and 18 cases for NGS. Conversion rates remained unaffected, and neither surgeon experienced increased blood loss or postoperative complications. A \"team learning curve\" effect in terms of operative time emerged after 12 cases, suggesting the importance of a cohesive surgical team.</p><p><strong>Conclusion: </strong>The robotic platform facilitated a relatively brief learning curve for low and intermediate complexity cases, irrespective of laparoscopic background, underscoring the benefits of team collaboration.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying an optimal cancer risk threshold for resection of pancreatic intraductal papillary mucinous neoplasms. 确定切除胰腺导管内乳头状黏液瘤的最佳癌症风险阈值。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-18 DOI: 10.1016/j.hpb.2024.10.006
Greg D Sacks, Luke Wojtalik, Sarah R Kaslow, Christina A Penfield, Stella K Kang, D B Hewitt, Ammar A Javed, Christopher L Wolfgang, R S Braithwaite

Background: IPMN consensus guidelines make implicit judgments on what cancer risk level should prompt surgery. We used decision modeling to estimate this cancer risk threshold (CRT) for BD-IPMN patients.

Methods: We created a decision model to compare quality-adjusted life years (QALYs) following surgery or surveillance for BD-IPMNs. We simulated treatment decisions for hypothetical patients, varying age, comorbidities and lesion location (pancreatic head/tail). The base case was a 60-year-old patient with mild comorbidities and pancreatic head IPMN. Probabilities, life expectancies, and utilities were incorporated from literature/public datasets. CRT was defined as the level of cancer risk at which the expected value of QALYs for surgery first exceeded that of surveillance.

Results: In the base case, surgery was preferred over surveillance, yielding 21.90 vs. 21.88 QALYs. The optimal CRT for a BD-IPMN patient depended on age, comorbidities, and location. CRT in the base case was 20 % and 3 % for an IPMN in the head and tail of the pancreas, respectively. Other drivers of preferred treatment were age and likelihood of postoperative mortality.

Conclusion: For BD-IPMNs, the optimal CRT varies depending on patient age and risk of surgical complications. Personalized risk threshold values could guide treatment decisions and inform future treatment consensus guidelines.

背景:IPMN共识指南对何种癌症风险水平应进行手术做出了隐性判断。我们使用决策模型来估算 BD-IPMN 患者的癌症风险阈值(CRT):我们创建了一个决策模型来比较 BD-IPMN 手术或监测后的质量调整生命年 (QALY)。我们模拟了不同年龄、合并症和病变位置(胰头/胰尾)的假设患者的治疗决策。基础病例是一名 60 岁的患者,合并症较轻,患有胰头 IPMN。概率、预期寿命和效用均来自文献/公共数据集。CRT被定义为癌症风险水平,在这一水平上,手术的QALYs预期值首先超过监测的QALYs预期值:结果:在基础病例中,手术优于监测,其 QALYs 为 21.90:21.88。BD-IPMN患者的最佳CRT取决于年龄、合并症和发病部位。在基础病例中,胰头和胰尾 IPMN 的 CRT 分别为 20% 和 3%。其他影响首选治疗的因素包括年龄和术后死亡的可能性:结论:对于BD-IPMNs,最佳CRT因患者年龄和手术并发症风险而异。个性化的风险阈值可指导治疗决策,并为未来的治疗共识指南提供参考。
{"title":"Identifying an optimal cancer risk threshold for resection of pancreatic intraductal papillary mucinous neoplasms.","authors":"Greg D Sacks, Luke Wojtalik, Sarah R Kaslow, Christina A Penfield, Stella K Kang, D B Hewitt, Ammar A Javed, Christopher L Wolfgang, R S Braithwaite","doi":"10.1016/j.hpb.2024.10.006","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.006","url":null,"abstract":"<p><strong>Background: </strong>IPMN consensus guidelines make implicit judgments on what cancer risk level should prompt surgery. We used decision modeling to estimate this cancer risk threshold (CRT) for BD-IPMN patients.</p><p><strong>Methods: </strong>We created a decision model to compare quality-adjusted life years (QALYs) following surgery or surveillance for BD-IPMNs. We simulated treatment decisions for hypothetical patients, varying age, comorbidities and lesion location (pancreatic head/tail). The base case was a 60-year-old patient with mild comorbidities and pancreatic head IPMN. Probabilities, life expectancies, and utilities were incorporated from literature/public datasets. CRT was defined as the level of cancer risk at which the expected value of QALYs for surgery first exceeded that of surveillance.</p><p><strong>Results: </strong>In the base case, surgery was preferred over surveillance, yielding 21.90 vs. 21.88 QALYs. The optimal CRT for a BD-IPMN patient depended on age, comorbidities, and location. CRT in the base case was 20 % and 3 % for an IPMN in the head and tail of the pancreas, respectively. Other drivers of preferred treatment were age and likelihood of postoperative mortality.</p><p><strong>Conclusion: </strong>For BD-IPMNs, the optimal CRT varies depending on patient age and risk of surgical complications. Personalized risk threshold values could guide treatment decisions and inform future treatment consensus guidelines.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of patient age on outcome of minimally invasive versus open pancreatoduodenectomy: a propensity score matched study. 患者年龄对微创与开腹胰十二指肠切除术结果的影响:倾向评分匹配研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-18 DOI: 10.1016/j.hpb.2024.10.008
Anouk M L H Emmen, Leia R Jones, Kongyuan Wei, Olivier Busch, Baiyong Shen, Giuseppe K Fusai, Yi-Ming Shyr, Igor Khatkov, Steve White, Ugo Boggi, Mustafa Kerem, I Q Molenaar, Bas G Koerkamp, Olivier Saint-Marc, Safi Dokmak, Susan van Dieren, Renzo Rozzini, Sebastiaan Festen, Rong Liu, Jin-Young Jang, Marc G Besselink, Mohammed A Hilal

Background: Pancreatoduodenectomy in elderly patients may be associated with increased postoperative mortality, but studies in minimally invasive pancreatoduodenectomy (MIPD) are scarce.

Methods: International multicenter retrospective study including patients aged >60 years undergoing MIPD (robot-assisted and laparoscopic) and open pancreatoduodenectomy (OPD), were categorized by age: 60-69, 70-79, and 80+ years. In each category, propensity score matching (PSM) was performed (1:1 ratio) between MIPD and OPD. Primary outcome was 30-day/in-hospital mortality.

Results: Among 3820 patients, we matched 1468 patients aged 60-69, 1154 patients aged 70-79, and 196 patients aged 80+ years. In patients aged 60-69 and 70-79 years, MIPD was associated with longer operative time, less blood loss and a longer length of stay. Major morbidity was higher after MIPD with similar 30-day/in-hospital mortality. The R0 resection rate was higher after MIPD. In patients aged 80+ years, besides a longer operative time in MIPD, outcomes were comparable between both groups.

Conclusion: This study found no evidence that increasing age worsens mortality of MIPD. MIPD was associated with longer operative time, higher rate of major morbidity, prolonged length of stay versus less blood loss and a higher R0 resection in patients aged 60-69 and 70-79 years. These differences continue in patients aged 80+ years, but became less evident.

背景:老年患者的胰十二指肠切除术可能会增加术后死亡率:老年患者接受胰十二指肠切除术可能会增加术后死亡率,但有关微创胰十二指肠切除术(MIPD)的研究却很少:国际多中心回顾性研究包括接受微创胰十二指肠切除术(机器人辅助和腹腔镜)和开腹胰十二指肠切除术(OPD)的 60 岁以上患者,按年龄分为 60-69 岁、70-79 岁和 80 岁以上。在每个类别中,在 MIPD 和 OPD 之间进行倾向得分匹配 (PSM)(1:1 比例)。主要结果是30天/住院死亡率:在 3820 名患者中,我们匹配了 1468 名 60-69 岁患者、1154 名 70-79 岁患者和 196 名 80 岁以上患者。在 60-69 岁和 70-79 岁的患者中,MIPD 与手术时间长、失血少和住院时间长相关。MIPD术后主要发病率较高,但30天/住院死亡率相似。MIPD术后的R0切除率更高。在80岁以上的患者中,除了MIPD的手术时间更长外,两组患者的治疗效果相当:结论:本研究没有发现任何证据表明,年龄的增加会降低MIPD的死亡率。在 60-69 岁和 70-79 岁的患者中,MIPD 与较长的手术时间、较高的主要发病率、较长的住院时间和较少的失血以及较高的 R0 切除率相关。这些差异在 80 岁以上的患者中继续存在,但变得不那么明显。
{"title":"Impact of patient age on outcome of minimally invasive versus open pancreatoduodenectomy: a propensity score matched study.","authors":"Anouk M L H Emmen, Leia R Jones, Kongyuan Wei, Olivier Busch, Baiyong Shen, Giuseppe K Fusai, Yi-Ming Shyr, Igor Khatkov, Steve White, Ugo Boggi, Mustafa Kerem, I Q Molenaar, Bas G Koerkamp, Olivier Saint-Marc, Safi Dokmak, Susan van Dieren, Renzo Rozzini, Sebastiaan Festen, Rong Liu, Jin-Young Jang, Marc G Besselink, Mohammed A Hilal","doi":"10.1016/j.hpb.2024.10.008","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.008","url":null,"abstract":"<p><strong>Background: </strong>Pancreatoduodenectomy in elderly patients may be associated with increased postoperative mortality, but studies in minimally invasive pancreatoduodenectomy (MIPD) are scarce.</p><p><strong>Methods: </strong>International multicenter retrospective study including patients aged >60 years undergoing MIPD (robot-assisted and laparoscopic) and open pancreatoduodenectomy (OPD), were categorized by age: 60-69, 70-79, and 80+ years. In each category, propensity score matching (PSM) was performed (1:1 ratio) between MIPD and OPD. Primary outcome was 30-day/in-hospital mortality.</p><p><strong>Results: </strong>Among 3820 patients, we matched 1468 patients aged 60-69, 1154 patients aged 70-79, and 196 patients aged 80+ years. In patients aged 60-69 and 70-79 years, MIPD was associated with longer operative time, less blood loss and a longer length of stay. Major morbidity was higher after MIPD with similar 30-day/in-hospital mortality. The R0 resection rate was higher after MIPD. In patients aged 80+ years, besides a longer operative time in MIPD, outcomes were comparable between both groups.</p><p><strong>Conclusion: </strong>This study found no evidence that increasing age worsens mortality of MIPD. MIPD was associated with longer operative time, higher rate of major morbidity, prolonged length of stay versus less blood loss and a higher R0 resection in patients aged 60-69 and 70-79 years. These differences continue in patients aged 80+ years, but became less evident.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Achievement of international benchmark outcomes for robotic pancreaticoduodenectomy in a low volume country. 在一个低产量国家实现机器人胰十二指肠切除术的国际基准成果。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-17 DOI: 10.1016/j.hpb.2024.10.003
Joel Lewin, Mehan Siriwardhane, Shinn Yeung

Background: Recently, there has been an increase in the utilisation of the robotic platform to perform minimally invasive pancreaticoduodenectomy in high volume centres, with the goal of reducing morbidity and improving patient outcomes. This study reports the successful implementation of a robotic pancreaticoduodenectomy (RPD) programme in the relatively low volume setting of Australia, measured against established, internationally accepted benchmarks for low-risk open pancreaticoduodenectomy (OPD).

Methods: Retrospective review of a prospectively maintained database for consecutive RPD at two Brisbane hospitals was performed, comparing data to internationally established benchmarks for low-risk OPD. A structured RPD programme was implemented by two surgeons across a study period spanning May 2017 to December 2023.

Results: Over the study period, seventy-two consecutive RPDs were performed, with 79 % for malignancy. Perioperative outcomes for transfusions, conversion rate, postoperative fistula rate, morbidity, mortality and oncological outcomes were all within established benchmark cutoffs for low-risk open pancreaticoduodenectomy (OPD), although operative time exceeded the benchmark value by 0.7hrs.

Conclusion: A carefully implemented RPD programme in the low volume Australian setting is feasible, with high quality outcomes achievable when compared to established benchmarks for low-risk OPD and to reported RPD series published by high volume pioneering centres.

背景:最近,越来越多的大手术量中心利用机器人平台进行微创胰十二指肠切除术,目的是降低发病率和改善患者预后。本研究报告了机器人胰十二指肠切除术(RPD)项目在澳大利亚相对较低的手术量环境中的成功实施情况,并与国际公认的低风险开放式胰十二指肠切除术(OPD)的既定基准进行了比较:方法:对布里斯班两家医院连续 RPD 的前瞻性数据库进行了回顾性审查,并将数据与国际公认的低风险 OPD 基准进行了比较。两名外科医生在2017年5月至2023年12月的研究期间实施了结构化RPD计划:在研究期间,共进行了72例连续RPD,其中79%为恶性肿瘤。围手术期的输血结果、转换率、术后瘘管率、发病率、死亡率和肿瘤结果均符合低风险开放式胰十二指肠切除术(OPD)的既定基准临界值,但手术时间超出基准值0.7小时:结论:在澳大利亚的低手术量环境中,精心实施的开放性胰十二指肠切除术是可行的,与低风险开放性胰十二指肠切除术的既定基准以及高手术量先驱中心发布的开放性胰十二指肠切除术系列报告相比,可获得高质量的结果。
{"title":"Achievement of international benchmark outcomes for robotic pancreaticoduodenectomy in a low volume country.","authors":"Joel Lewin, Mehan Siriwardhane, Shinn Yeung","doi":"10.1016/j.hpb.2024.10.003","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.003","url":null,"abstract":"<p><strong>Background: </strong>Recently, there has been an increase in the utilisation of the robotic platform to perform minimally invasive pancreaticoduodenectomy in high volume centres, with the goal of reducing morbidity and improving patient outcomes. This study reports the successful implementation of a robotic pancreaticoduodenectomy (RPD) programme in the relatively low volume setting of Australia, measured against established, internationally accepted benchmarks for low-risk open pancreaticoduodenectomy (OPD).</p><p><strong>Methods: </strong>Retrospective review of a prospectively maintained database for consecutive RPD at two Brisbane hospitals was performed, comparing data to internationally established benchmarks for low-risk OPD. A structured RPD programme was implemented by two surgeons across a study period spanning May 2017 to December 2023.</p><p><strong>Results: </strong>Over the study period, seventy-two consecutive RPDs were performed, with 79 % for malignancy. Perioperative outcomes for transfusions, conversion rate, postoperative fistula rate, morbidity, mortality and oncological outcomes were all within established benchmark cutoffs for low-risk open pancreaticoduodenectomy (OPD), although operative time exceeded the benchmark value by 0.7hrs.</p><p><strong>Conclusion: </strong>A carefully implemented RPD programme in the low volume Australian setting is feasible, with high quality outcomes achievable when compared to established benchmarks for low-risk OPD and to reported RPD series published by high volume pioneering centres.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatic surgery after preoperative biliary drainage in periampullary cancers: does timing matter? A systematic review and meta-analysis. 胰周癌患者术前胆道引流后进行胰腺手术:时机是否重要?系统回顾和荟萃分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-15 DOI: 10.1016/j.hpb.2024.10.001
Mohamed Maatouk, Ghassen H Kbir, Anis Ben Dhaou, Mariem Nouira, Atef Chamekh, Sami Daldoul, Sofien Sayari, Mounir Ben Moussa

Background: Preoperative biliary drainage (PBD) has been introduced to control the negative effects of obstructive jaundice in patients undergoing pancreaticoduodenectomy (PD). The optimal time interval between PBD and PD remains unclear. The purpose of our systematic review and meta-analysis was to evaluate the optimal period for PBD before PD.

Methods: Studies were searched in PubMed, Science Direct, Google Scholar and Cochrane Library until 30 March 2024. Studies using PBD in patients with malignant obstructive jaundice that compared the short duration group (SDG) with prolonged duration group (PDG) were included in this study. The definitions of short and prolonged drainage were based on cut-off times reported in the included studies.

Results: Twelve studies were included. Based on the available data, short and prolonged drainage periods were defined by comparing the outcomes of surgeries performed within specific cut-off times of 2 weeks, 3 weeks, and 4 weeks after PBD. No significant differences were observed between the SDG and PDG in mortality, major morbidity, pancreatic fistula, post pancreatectomy haemorrhage, septic complications, operative time, and hospital stay, regardless of the delay of surgery.

Conclusion: When PBD is needed, pancreatic resection could be performed at the earliest possible stage after achieving optimal perioperative care.

背景:术前胆道引流术(PBD)是为了控制胰十二指肠切除术(PD)患者阻塞性黄疸的负面影响。PBD 和 PD 之间的最佳时间间隔仍不明确。我们的系统综述和荟萃分析旨在评估胰十二指肠切除术前进行胰十二指肠切除术的最佳时间间隔:在 PubMed、Science Direct、Google Scholar 和 Cochrane Library 中检索了截至 2024 年 3 月 30 日的研究。本研究纳入了在恶性阻塞性黄疸患者中使用 PBD 的研究,这些研究对短时间组(SDG)和长时间组(PDG)进行了比较。短时间引流和长时间引流的定义基于纳入研究中报告的截止时间:结果:共纳入 12 项研究。根据现有数据,通过比较在 PBD 后 2 周、3 周和 4 周的特定截断时间内进行手术的结果来定义引流时间短和引流时间长。在死亡率、主要发病率、胰瘘、胰腺切除术后出血、化脓性并发症、手术时间和住院时间方面,SDG 和 PDG 之间没有观察到明显差异,无论手术延迟与否:结论:当需要进行胰十二指肠切除术时,可在实现最佳围手术期护理后尽早进行胰腺切除术。
{"title":"Pancreatic surgery after preoperative biliary drainage in periampullary cancers: does timing matter? A systematic review and meta-analysis.","authors":"Mohamed Maatouk, Ghassen H Kbir, Anis Ben Dhaou, Mariem Nouira, Atef Chamekh, Sami Daldoul, Sofien Sayari, Mounir Ben Moussa","doi":"10.1016/j.hpb.2024.10.001","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.001","url":null,"abstract":"<p><strong>Background: </strong>Preoperative biliary drainage (PBD) has been introduced to control the negative effects of obstructive jaundice in patients undergoing pancreaticoduodenectomy (PD). The optimal time interval between PBD and PD remains unclear. The purpose of our systematic review and meta-analysis was to evaluate the optimal period for PBD before PD.</p><p><strong>Methods: </strong>Studies were searched in PubMed, Science Direct, Google Scholar and Cochrane Library until 30 March 2024. Studies using PBD in patients with malignant obstructive jaundice that compared the short duration group (SDG) with prolonged duration group (PDG) were included in this study. The definitions of short and prolonged drainage were based on cut-off times reported in the included studies.</p><p><strong>Results: </strong>Twelve studies were included. Based on the available data, short and prolonged drainage periods were defined by comparing the outcomes of surgeries performed within specific cut-off times of 2 weeks, 3 weeks, and 4 weeks after PBD. No significant differences were observed between the SDG and PDG in mortality, major morbidity, pancreatic fistula, post pancreatectomy haemorrhage, septic complications, operative time, and hospital stay, regardless of the delay of surgery.</p><p><strong>Conclusion: </strong>When PBD is needed, pancreatic resection could be performed at the earliest possible stage after achieving optimal perioperative care.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined division of the splenic vessels and pancreatic parenchyma during laparoscopic distal pancreatectomy is a safe alternative to separate division: a single-institution retrospective study. 腹腔镜胰腺远端切除术中合并分割脾血管和胰腺实质是一种安全的替代单独分割的方法:一项单一机构的回顾性研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-11 DOI: 10.1016/j.hpb.2024.10.002
Kareem Sadek, Andrew Shaker, Mary Tice, John A Stauffer

Background: Limited data exists regarding the safety and outcomes of combined division of the splenic vessels with the pancreatic parenchyma during laparoscopic distal pancreatectomy (LDP). This study aims to evaluate the combined division technique.

Methods: Patients who underwent LDP for pancreatic cancer from April 2011 to December 2022 were retrospectively reviewed and categorized into the following groups: combined (CV) versus separate (SV) division of the splenic vein; combined (CA) versus separate (SA) division of the splenic artery; and combined (CAV) versus separate (SAV) division of the splenic artery and vein, with or without the pancreatic parenchyma.

Results: Among the 80 patients included, 44 underwent CV and 36 underwent SV. Operative time and major morbidity were significantly lower in CV compared with SV. Similar findings were observed in CAV versus SAV, as well as lower blood loss in CAV. Operative time was significantly lower in CA versus SA. Pancreatic fistula and postpancreatectomy hemorrhage rates showed no significant differences between groups. No patient developed splenic arteriovenous fistula in follow-up.

Conclusion: Combined division of the splenic vessels with the pancreatic parenchyma during LDP is safe and associated with improved outcomes compared with separate division.

背景:有关腹腔镜胰腺远端切除术(LDP)中脾血管与胰腺实质联合分割的安全性和结果的数据有限。本研究旨在评估联合分割技术:回顾性研究2011年4月至2022年12月期间因胰腺癌接受腹腔镜胰腺切除术的患者,并将其分为以下几组:脾静脉联合(CV)与单独(SV)分割;脾动脉联合(CA)与单独(SA)分割;脾动脉与静脉联合(CAV)与单独(SAV)分割,有无胰腺实质:在纳入的 80 位患者中,44 位接受了 CV,36 位接受了 SV。与 SV 相比,CV 的手术时间和主要发病率明显较低。CAV与SAV的结果相似,CAV的失血量更低。CA与SA相比,手术时间明显更短。胰瘘和胰腺切除术后出血率在组间无明显差异。随访中没有患者出现脾动静脉瘘:结论:在 LDP 期间将脾血管与胰腺实质合并分割是安全的,与单独分割相比,其结果更好。
{"title":"Combined division of the splenic vessels and pancreatic parenchyma during laparoscopic distal pancreatectomy is a safe alternative to separate division: a single-institution retrospective study.","authors":"Kareem Sadek, Andrew Shaker, Mary Tice, John A Stauffer","doi":"10.1016/j.hpb.2024.10.002","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.002","url":null,"abstract":"<p><strong>Background: </strong>Limited data exists regarding the safety and outcomes of combined division of the splenic vessels with the pancreatic parenchyma during laparoscopic distal pancreatectomy (LDP). This study aims to evaluate the combined division technique.</p><p><strong>Methods: </strong>Patients who underwent LDP for pancreatic cancer from April 2011 to December 2022 were retrospectively reviewed and categorized into the following groups: combined (CV) versus separate (SV) division of the splenic vein; combined (CA) versus separate (SA) division of the splenic artery; and combined (CAV) versus separate (SAV) division of the splenic artery and vein, with or without the pancreatic parenchyma.</p><p><strong>Results: </strong>Among the 80 patients included, 44 underwent CV and 36 underwent SV. Operative time and major morbidity were significantly lower in CV compared with SV. Similar findings were observed in CAV versus SAV, as well as lower blood loss in CAV. Operative time was significantly lower in CA versus SA. Pancreatic fistula and postpancreatectomy hemorrhage rates showed no significant differences between groups. No patient developed splenic arteriovenous fistula in follow-up.</p><p><strong>Conclusion: </strong>Combined division of the splenic vessels with the pancreatic parenchyma during LDP is safe and associated with improved outcomes compared with separate division.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of chronic obstructive pulmonary disease on risk for complications after pancreatoduodenectomy - a single centre cohort study. 慢性阻塞性肺病对胰十二指肠切除术后并发症风险的影响--一项单中心队列研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-11 DOI: 10.1016/j.hpb.2024.10.005
Patrik Larsson, Oskar Swartling, Giampaolo Perri, Kaveh Vaez, Marcus Holmberg, Fredrik Klevebro, Stefan Gilg, Ernesto Sparrelid, Poya Ghorbani

Background: The association between chronic obstructive pulmonary disease (COPD) and risk for postoperative complications after pancreatic surgery has not been clarified. The aim of this study was to investigate if COPD is associated with increased risk for postoperative complications after pancreatoduodenectomy.

Methods: All patients aged ≥18 years undergoing pancreatoduodenectomy from 2008 to 2019 at a high-volume tertiary centre for pancreatic cancer surgery were included. COPD was defined as an established diagnosis according to the International Statistical Classification of Diseases. The primary outcome was Clavien-Dindo-score (CD)≥ IIIa.

Results: Out of 1009 available patients, 57 (5.6 %) had a diagnosis of COPD. There was no association between COPD and CD≥ IIIa (25.5 % vs. 29.8 % p-value 0.471). COPD was associated with an increased risk for postoperative pancreatic fistula (POPF) (odds ratio [OR] 3.06, 95 % confidence interval 1.62-5.89; p < 0.001). The 12 months mortality rate was higher among patients with COPD compared to patients without COPD, although not statistically significant (28.07 % vs., 18.17 %, p-value = 0.063).

Conclusion: COPD was associated with increased risk for POPF. These results imply that among patients deemed fit enough to undergo surgery, COPD should be thoroughly evaluated in the risk stratification.

背景:慢性阻塞性肺疾病(COPD)与胰腺手术后并发症风险之间的关系尚未明确。本研究旨在探讨慢性阻塞性肺病是否与胰十二指肠切除术后并发症风险增加有关:方法:纳入2008年至2019年期间在一家胰腺癌手术量较大的三级中心接受胰十二指肠切除术的所有年龄≥18岁的患者。根据《国际疾病统计分类》,慢性阻塞性肺病被定义为已确诊的疾病。主要结果为Clavien-Dindo评分(CD)≥ IIIa:在 1009 名患者中,有 57 人(5.6%)被诊断为慢性阻塞性肺病。慢性阻塞性肺病与 CD≥ IIIa 之间没有关联(25.5% 对 29.8%,P 值 0.471)。慢性阻塞性肺病与术后胰瘘 (POPF) 的风险增加有关(几率比 [OR] 3.06,95% 置信区间 1.62-5.89;P 结论:慢性阻塞性肺病与术后胰瘘的风险增加有关:慢性阻塞性肺病与 POPF 风险增加有关。这些结果表明,在被认为适合接受手术的患者中,在进行风险分层时应全面评估慢性阻塞性肺病。
{"title":"The impact of chronic obstructive pulmonary disease on risk for complications after pancreatoduodenectomy - a single centre cohort study.","authors":"Patrik Larsson, Oskar Swartling, Giampaolo Perri, Kaveh Vaez, Marcus Holmberg, Fredrik Klevebro, Stefan Gilg, Ernesto Sparrelid, Poya Ghorbani","doi":"10.1016/j.hpb.2024.10.005","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.005","url":null,"abstract":"<p><strong>Background: </strong>The association between chronic obstructive pulmonary disease (COPD) and risk for postoperative complications after pancreatic surgery has not been clarified. The aim of this study was to investigate if COPD is associated with increased risk for postoperative complications after pancreatoduodenectomy.</p><p><strong>Methods: </strong>All patients aged ≥18 years undergoing pancreatoduodenectomy from 2008 to 2019 at a high-volume tertiary centre for pancreatic cancer surgery were included. COPD was defined as an established diagnosis according to the International Statistical Classification of Diseases. The primary outcome was Clavien-Dindo-score (CD)≥ IIIa.</p><p><strong>Results: </strong>Out of 1009 available patients, 57 (5.6 %) had a diagnosis of COPD. There was no association between COPD and CD≥ IIIa (25.5 % vs. 29.8 % p-value 0.471). COPD was associated with an increased risk for postoperative pancreatic fistula (POPF) (odds ratio [OR] 3.06, 95 % confidence interval 1.62-5.89; p < 0.001). The 12 months mortality rate was higher among patients with COPD compared to patients without COPD, although not statistically significant (28.07 % vs., 18.17 %, p-value = 0.063).</p><p><strong>Conclusion: </strong>COPD was associated with increased risk for POPF. These results imply that among patients deemed fit enough to undergo surgery, COPD should be thoroughly evaluated in the risk stratification.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic versus open pancreaticoduodenectomy in octogenarians: a comparative propensity score analysis of perioperative outcomes. 八旬老人的机器人胰十二指肠切除术与开腹胰十二指肠切除术:围手术期结果的倾向评分比较分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-10 DOI: 10.1016/j.hpb.2024.10.004
Andres A Abreu, Amr I Al Abbas, Jennie Meier, Ricardo E Nunez-Rocha, Emile Farah, Cecilia G Ethun, Matthew R Porembka, John C Mansour, Adam C Yopp, Herbert J Zeh Iii, Sam C Wang, Patricio M Polanco

Background: Compared to open pancreaticoduodenectomies (OPD), the robotic (RPD) approach decreases the rate of complication and the length of stay (LOS). However, it remains unknown if these benefits persist in octogenarians, who are at higher risk for perioperative morbidity and mortality.

Methods: A retrospective analysis of the ACS-NSQIP database was performed to identify patients aged 80 years or older who underwent PD for pancreatic adenocarcinoma between 2015-2021. Patients who underwent RPD or OPD were compared using inversed probability weighting of the propensity score. Outcomes assessed include operative time, LOS, non-home discharge, major complications, unplanned readmission, return to the operating room, mortality, and clinically relevant postoperative pancreatic fistula.

Results: Of 30,751 patients, 1720 were octogenarians. One thousand six hundred twenty-five patients (94 %) underwent OPD, and 95 (6 %) underwent RPD. RPD was significantly associated with a reduced incidence of major complications (32.6 % vs. 45.6 %; p < 0.01) and a lower rate of non-home discharge (24.7 % vs. 34.3%; p < 0.05). However, RPD was associated with a longer operative time (438 min vs. 342 min; p < 0.0001). There was no difference in other assessed outcomes.

Conclusion: RPD may reduce major postoperative complications and non-home discharges compared to the open approach for octogenarians.

背景:与开腹胰十二指肠切除术(OPD)相比,机器人胰十二指肠切除术(RPD)可降低并发症发生率,缩短住院时间(LOS)。然而,对于围手术期发病率和死亡率风险较高的八旬老人来说,这些优势是否依然存在仍是未知数:对 ACS-NSQIP 数据库进行回顾性分析,以确定在 2015-2021 年间接受胰腺腺癌手术的 80 岁或以上患者。采用反概率加权倾向评分对接受 RPD 或 OPD 的患者进行比较。评估的结果包括手术时间、LOS、非居家出院、主要并发症、非计划再入院、返回手术室、死亡率和临床相关的术后胰瘘:在 30751 名患者中,有 1720 名八旬老人。1625名患者(94%)接受了手术治疗,95名患者(6%)接受了RPD治疗。RPD明显降低了主要并发症的发生率(32.6% 对 45.6%;P < 0.01),降低了非居家出院率(24.7% 对 34.3%;P < 0.05)。不过,RPD的手术时间更长(438 分钟对 342 分钟;P < 0.0001)。其他评估结果没有差异:结论:与开腹手术相比,RPD可减少八旬老人术后的主要并发症和非居家出院。
{"title":"Robotic versus open pancreaticoduodenectomy in octogenarians: a comparative propensity score analysis of perioperative outcomes.","authors":"Andres A Abreu, Amr I Al Abbas, Jennie Meier, Ricardo E Nunez-Rocha, Emile Farah, Cecilia G Ethun, Matthew R Porembka, John C Mansour, Adam C Yopp, Herbert J Zeh Iii, Sam C Wang, Patricio M Polanco","doi":"10.1016/j.hpb.2024.10.004","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.10.004","url":null,"abstract":"<p><strong>Background: </strong>Compared to open pancreaticoduodenectomies (OPD), the robotic (RPD) approach decreases the rate of complication and the length of stay (LOS). However, it remains unknown if these benefits persist in octogenarians, who are at higher risk for perioperative morbidity and mortality.</p><p><strong>Methods: </strong>A retrospective analysis of the ACS-NSQIP database was performed to identify patients aged 80 years or older who underwent PD for pancreatic adenocarcinoma between 2015-2021. Patients who underwent RPD or OPD were compared using inversed probability weighting of the propensity score. Outcomes assessed include operative time, LOS, non-home discharge, major complications, unplanned readmission, return to the operating room, mortality, and clinically relevant postoperative pancreatic fistula.</p><p><strong>Results: </strong>Of 30,751 patients, 1720 were octogenarians. One thousand six hundred twenty-five patients (94 %) underwent OPD, and 95 (6 %) underwent RPD. RPD was significantly associated with a reduced incidence of major complications (32.6 % vs. 45.6 %; p < 0.01) and a lower rate of non-home discharge (24.7 % vs. 34.3%; p < 0.05). However, RPD was associated with a longer operative time (438 min vs. 342 min; p < 0.0001). There was no difference in other assessed outcomes.</p><p><strong>Conclusion: </strong>RPD may reduce major postoperative complications and non-home discharges compared to the open approach for octogenarians.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits and barriers to accreditation of HPB center and fellowship programs in Europe: a strength-weakness-opportunity-and-threats (SWOT) analysis by an E-AHPBA-ESSO-UEMS ad hoc working committee 欧洲 HPB 中心和研究金项目认证的优势和障碍:E-AHPBA-ESSO-UEMS 特设工作委员会的优势-劣势-机会-威胁(SWOT)分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2024-10-01 DOI: 10.1016/j.hpb.2024.06.011
Kjetil Soreide , Frederik Berrevoet , Isabella Frigerio , Tom Gallagher , Johanna Laukkarinen , Stefan Gilg , Andreas Schnitzbauer , Stefan Stättner , Cristina D. Taboada , Wojciech G. Polak , Ajith K. Siriwardena , Marc G. Besselink

Background

Training in HPB surgery lacks uniformity across regions covered by the E-AHPBA. Accreditation has been in place for centers and fellowship programs, but with low uptake. The decision whether to continue, change or cease such accreditation is being discussed. Thus, a strengths, weaknesses, opportunities, and threats (SWOT) analysis was conducted.

Methods

A mixed-methods, cross-sectional study among stakeholders in E-AHPBA, ESSO and UEMS under the E-AHPBA executive council was founded, ensuring representation by gender and geographic distribution.

Results

Responses were collected from across E-AHPBA regions, with response from 15 of 24 subchapters. The most frequent and recurring themes are presented in a SWOT matrix which allows for paired evaluations of factors deemed to be helpful (Strengths and Opportunities), those that are harmful (Weaknesses and Threats).

Conclusion

This study identified both helpful and harmful effects to an accreditation process of HPB centers or HPB fellowship training across the E-AHPBA membership region.
Formal accreditation of centers is not within the scope, nor jurisdiction nor financial capacity for E-AHPBA in the current situation. A strong interest in formal HPB training should be capitalized into E-AHPBA strategic planning towards a structured accreditation system for HPB fellowship programs or HPB training tracks.
背景:E-AHPBA覆盖的各地区在HPB手术培训方面缺乏统一性。中心和研究金项目已通过鉴定,但采用率较低。目前正在讨论是继续、改变还是停止这种认证。因此,我们进行了优势、劣势、机会和威胁(SWOT)分析:方法:在 E-AHPBA 执行理事会下的 E-AHPBA、ESSO 和 UEMS 的利益相关者中开展了一项混合方法横断面研究,确保了性别和地理分布的代表性:结果:收集到了来自 E-AHPBA 各地区的答复,其中 24 个分会中有 15 个作出了答复。最常见和重复出现的主题在 SWOT 矩阵中呈现,该矩阵允许对被认为有益的因素(优势和机会)和有害的因素(弱点和威胁)进行配对评估:本研究发现,在整个欧洲-亚洲高血压协会会员地区,对高血压治疗中心或高血压治疗研究金培训的认证过程既有帮助,也有不利影响。在目前情况下,对中心进行正式认证不属于 E-AHPBA 的工作范围,也不属于 E-AHPBA 的管辖范围或财政能力范围。对正规的 HPB 培训的浓厚兴趣应被纳入 E-AHPBA 的战略规划,以建立一个结构化的 HPB 研究金项目或 HPB 培训轨道的认证体系。
{"title":"Benefits and barriers to accreditation of HPB center and fellowship programs in Europe: a strength-weakness-opportunity-and-threats (SWOT) analysis by an E-AHPBA-ESSO-UEMS ad hoc working committee","authors":"Kjetil Soreide ,&nbsp;Frederik Berrevoet ,&nbsp;Isabella Frigerio ,&nbsp;Tom Gallagher ,&nbsp;Johanna Laukkarinen ,&nbsp;Stefan Gilg ,&nbsp;Andreas Schnitzbauer ,&nbsp;Stefan Stättner ,&nbsp;Cristina D. Taboada ,&nbsp;Wojciech G. Polak ,&nbsp;Ajith K. Siriwardena ,&nbsp;Marc G. Besselink","doi":"10.1016/j.hpb.2024.06.011","DOIUrl":"10.1016/j.hpb.2024.06.011","url":null,"abstract":"<div><h3>Background</h3><div>Training in HPB surgery lacks uniformity across regions covered by the E-AHPBA. Accreditation has been in place for centers and fellowship programs, but with low uptake. The decision whether to continue, change or cease such accreditation is being discussed. Thus, a strengths, weaknesses, opportunities, and threats (SWOT) analysis was conducted.</div></div><div><h3>Methods</h3><div>A mixed-methods, cross-sectional study among stakeholders in E-AHPBA, ESSO and UEMS under the E-AHPBA executive council was founded, ensuring representation by gender and geographic distribution.</div></div><div><h3>Results</h3><div>Responses were collected from across E-AHPBA regions, with response from 15 of 24 subchapters. The most frequent and recurring themes are presented in a SWOT matrix which allows for paired evaluations of factors deemed to be <em>helpful</em> (Strengths and Opportunities), those that are <em>harmful</em> (Weaknesses and Threats).</div></div><div><h3>Conclusion</h3><div>This study identified both helpful and harmful effects to an accreditation process of HPB centers or HPB fellowship training across the E-AHPBA membership region.</div><div>Formal accreditation of centers is not within the scope, nor jurisdiction nor financial capacity for E-AHPBA in the current situation. A strong interest in formal HPB training should be capitalized into E-AHPBA strategic planning towards a structured accreditation system for HPB fellowship programs or HPB training tracks.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 10","pages":"Pages 1254-1260"},"PeriodicalIF":2.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141603519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hpb
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1